ArticleMolecular biology international2012

Loss of RASSF2 Enhances Tumorigencity of Lung Cancer Cells and Confers Resistance to Chemotherapy.

Jennifer Clark et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.